Predictors of delay in diagnosis and treatment in diffuse large B-cell lymphoma and impact on survival. [electronic resource]
Producer: 20150401Description: 492-500 p. digitalISSN:- 1365-2141
- Aged
- Antibodies, Monoclonal, Murine-Derived -- administration & dosage
- Antineoplastic Combined Chemotherapy Protocols -- administration & dosage
- Biopsy, Fine-Needle
- Combined Modality Therapy
- Comorbidity
- Cyclophosphamide -- administration & dosage
- Delayed Diagnosis -- adverse effects
- Disease-Free Survival
- Doxorubicin -- administration & dosage
- Female
- Humans
- Kaplan-Meier Estimate
- Lymphoma, Large B-Cell, Diffuse -- diagnosis
- Male
- Middle Aged
- Ontario -- epidemiology
- Prednisone -- administration & dosage
- Proportional Hazards Models
- Radiotherapy, Adjuvant
- Referral and Consultation
- Retrospective Studies
- Risk Factors
- Rituximab
- Socioeconomic Factors
- Treatment Outcome
- Vincristine -- administration & dosage
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.